Document is current
Any future updates will be listed below
-
Authors
Choi, Ju-Won
Kim, Hyeyoon
Ham, Sung-Hee
Han, Ye-Jin
Kim, Sung-Eun
Sung, Mi-Kyung
-
Clinical Trials BETA
Clinical trials referenced in this document:
kct0010817 at Clinical Research Information Service, Republic of KoreaDocuments that mention this clinical trial
Probiotic Bifidobacterium bifidum BGN4 supplementation modulates gut microbiome composition and reduces circulating zonulin, TNFα, and insulin in adults with excess adiposity: a randomized, double-blind, placebo-controlled trial
https://doi.org/10.1186/s12986-026-01124-1
-
Funding
Funding for this research was provided by:
National Research Foundation of Korea (NRF) grant funded by the Korea government (2023R1A2C1005313)
National Research Foundation of Korea (NRF) grant funded by the Korea government (2022R1A2C1004626)
- License Information
-
More Information
Article History
Received: 31 December 2025
Accepted: 16 April 2026
First Online: 11 May 2026
Declarations
:
: This study was approved by the Institutional Review Board of Sookmyung Women’s University, Korea (reference number: SMWU-2402-BR-126–01) and was registered with the Clinical Research Information Service (CRIS), Korea National Institute of Health. This study is registered at . The registration identification number is KCT0010817 ( = ).
: Not applicable.
: The authors declare no competing interests.
